Lynn Hallarman, MD
Dr. Hallarman is the director of palliative care services and an associate professor of medicine at Stony Brook University Medical Center. She received her medical degree from Yale School of Medicine in 1993 and completed her internal medicine residency at Strong Memorial Hospital in Rochester, NY, in 1996. She is a board-certified palliative care physician. Her palliative services program, begun by her in 2007, has been recognized on the national level as a recipient of the National Consensus Project Quality in Palliative Care Leadership Award and is among the first in the nation to receive advanced certification from the Joint Commission in 2013 and again in 2015 and 2017. Dr. Hallarman participates extensively as a clinical educator on a local, state, and national level. She is the recipient of the 2010 Stony Brook Medicine Education Innovation Award for her curriculum work and has been grant funded by the National End-of-Life/Palliative Education Resource Center for medical student curriculum development. She is the recent recipient of the Stony Brook Medical School’s highest teaching award, an educational consultant to the Center to Advance Palliative Care (CAPC), and the co-author of CAPC’s web-based Pain Management curriculum. Dr. Hallarman recently completed a yearlong residence as a congressional fellow working for the U.S. Senate Committee on Finance, where she participated in developing the opioid legislation package recently signed by the president.
Conducting a comprehensive pain assessment to guide safe and effective treatment.
Selecting a safe and appropriate analgesic for patients with serious illness based on the pain assessment.
Patient and family factors that influence prescribing decisions for patients with serious illness.
Integrating routine risk assessment for substance use disorder when considering or using opioid therapy.
Designing a safe and effective opioid trial for the patient with serious illness.
Safe and appropriate opioid prescribing for the opioid-naive patient with serious illness.
Four indications for using short-acting opioids.
Ongoing evaluation of opioid benefits, risks, and side effects for the patient with serious illness.
Guidance on safe conversion to long-acting opioids for patients with serious illness.
Prescribing practice for long half-life opioids, converting from one opioid to another, and accounting for incomplete cross-tolerance.
Changing the route of opioid delivery, rotating opioids, advanced opioid conversions, and tapering opioids.
Safe opioid prescribing in older adults, cognitively impaired patients, children, and the imminently dying, including patient-controlled analgesia.
Pain management for patients with serious illness and high risk for substance use disorder, including risk assessment, monitoring, and when to refer for safe pain management.
Safe opioid prescribing for patients with serious illness, using the Federation of State Medical Boards (FSMB) Guidelines for the Chronic Use of Opioid Analgesics.